In contrast, immunostaining of ESCC cells and analysis of clinical data revealed that low GCH1 expression was a significantly poor prognostic factor, and in vitro experimental results revealed that low GCH1 expression contributed to cell proliferation and resulted in resistance to cisplatin. Here, GCH1 is linked to esophageal squamous cell carcinoma.